CSIMarket
 


Scynexis inc   (SCYX)
Other Ticker:  
 

Scynexis Inc 's Tangible Leverage Ratio

SCYX's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth




SCYX Tangible Leverage Ratio (Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
Y / Y Tangible Equity Change 401.31 % 295.76 % 76.49 % 55.59 % -39.12 %
Y / Y Total Liabilities Change 128.11 % 111.77 % 80.4 % -1.79 % 27.05 %
Tangible Leverage Ratio MRQ 2.8 2.9 3.51 2.84 6.15
Overall Ranking # # # # #
Seq. Tangible Equity Change 24.28 % 12.25 % 138.1 % 50.92 % -1.89 %
Seq. Total Liabilities Change 19.78 % -7.06 % 193.87 % -30.27 % 11.2 %



Tangible Leverage Ratio second quarter 2021 Comment
Despite net new borrowings of 19.78% Scynexis Inc managed to improve Tangible Leverage Ratio in the second quarter 2021 to 2.8, above company's average Tangible Leverage Ratio.

Within Major Pharmaceutical Preparations industry in the second quarter 2021, 303 other companies have achieved lower Tangible Leverage Ratio than Scynexis Inc . While total ranking remained unchanged compare to previous quarter at no. .

Explain Tangible Leverage Ratio?
What is SCYX Market Share?
Tangible Leverage Ratio second quarter 2021 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 304
Healthcare Sector # 736
Overall Market # 2902


Tangible Leverage Ratio Statistics
High Average Low
6.15 1.65 0.07
(Jun 30 2020)   (Sep 30 2015)




Financial Statements
Scynexis Inc 's Tangible Equity $ 32 Millions Visit SCYX's Balance sheet
Scynexis Inc 's Total Liabilities $ 89 Millions Visit SCYX's Balance sheet
Source of SCYX's Sales Visit SCYX's Sales by Geography




Companies with similar Tangible Leverage Ratio in the quarter endingJun 30 2021, within Major Pharmaceutical Preparations Industry Tangible Leverage RatioJun 30 2021 MRQ Total LiabilitiesJun 30 2021 MRQ Tangible Equity
Dynavax Technologies Corp  6.55 $ 531.632  Millions$ 81.155  Millions
Dicerna Pharmaceuticals Inc   6.55 $ 727.418  Millions$ 111.074  Millions
Xeris Pharmaceuticals Inc   6.11 $ 121.508  Millions$ 19.888  Millions
Avid Bioservices Inc   5.06 $ 225.895  Millions$ 44.636  Millions
Chembio Diagnostics Inc   5.02 $ 34.473  Millions$ 6.874  Millions
Phibro Animal Health Corp  4.88 $ 602.796  Millions$ 123.568  Millions
Acura Pharmaceuticals Inc  4.70 $ 1.514  Millions$ 0.322  Millions
Sarepta Therapeutics Inc   4.64 $ 2,184.721  Millions$ 471.003  Millions
Jaguar Health inc   4.55 $ 37.754  Millions$ 8.291  Millions
Recro Pharma Inc   4.35 $ 96.014  Millions$ 22.097  Millions
Tricida Inc   4.16 $ 145.211  Millions$ 34.929  Millions
Evolus Inc   4.10 $ 133.725  Millions$ 32.620  Millions
Harrow Health Inc   4.06 $ 83.763  Millions$ 20.634  Millions
Ionis Pharmaceuticals Inc   3.46 $ 1,914.395  Millions$ 553.301  Millions
Sonnet Biotherapeutics Holdings Inc   3.45 $ 4.716  Millions$ 1.369  Millions
Immunogen inc   3.40 $ 232.981  Millions$ 68.465  Millions
Mei Pharma Inc   3.21 $ 132.736  Millions$ 41.362  Millions
Alnylam Pharmaceuticals Inc   3.11 $ 2,656.067  Millions$ 853.362  Millions
Scynexis inc   2.80 $ 88.811  Millions$ 31.748  Millions
Alpine Immune Sciences Inc   2.65 $ 115.987  Millions$ 43.831  Millions
China Pharma Holdings Inc   2.11 $ 13.420  Millions$ 6.360  Millions
Sonoma Pharmaceuticals Inc  2.06 $ 9.500  Millions$ 4.621  Millions
Rigel Pharmaceuticals Inc  1.96 $ 133.488  Millions$ 68.110  Millions
Fibrogen Inc   1.96 $ 548.038  Millions$ 279.851  Millions
Evoke Pharma Inc  1.94 $ 11.592  Millions$ 5.966  Millions
Travere Therapeutics Inc   1.90 $ 344.263  Millions$ 181.416  Millions
Cumberland Pharmaceuticals Inc   1.89 $ 39.831  Millions$ 21.038  Millions
Humanigen Inc  1.79 $ 78.035  Millions$ 43.695  Millions
Perrigo Company Plc  1.67 $ 5,331.700  Millions$ 3,197.300  Millions
Timber Pharmaceuticals Inc   1.64 $ 4.592  Millions$ 2.803  Millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

VMAC's Profile

Stock Price

VMAC's Financials

Business Description

Fundamentals

Charts & Quotes

VMAC's News

Suppliers

VMAC's Competitors

Customers & Markets

Economic Indicators

VMAC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071